North America Epilepsy Devices Market 2022-2028
MARKET OUTLOOK
According to Triton Market Research, the epilepsy devices market in North America is estimated to gather a compound annual growth rate of 8.34% over the forecast years 2022 to 2028. The United States and Canada are examined in the region.
Factors such as advanced healthcare infrastructure, government policies, and key players expanding operations are fueling the market on a progressive path. Companies like Boston Scientific Corporation and Empatica are among the major firms launching new products to gain a competitive edge in the studied market. This is mainly owing to the rise in epilepsy cases across the US and Canada. As per industry sources, around one in 26 people are diagnosed with epilepsy once in their lifetime. Therefore, the rising cases are anticipated to boost the adoption of epilepsy monitoring devices over the forecast period.
Considering the market’s growth in the US, there is a rise in epilepsy cases among the elderly population that has soared the demand for effective treatment measures. In this regard, wearable devices and homecare treatments have gained momentum in recent years. The prominent wearable devices include watches, cameras, anti-suffocation pillows, and bracelets. As a result, the rising need for advanced medical technologies to treat seizures propels the epilepsy devices market on a growth path.
COMPETITIVE OUTLOOK
The major enterprises in the epilepsy devices market consist of LivaNova Plc, Cadwell Industries Inc, Nihon Kohden Corporation, Medtronic Plc, and Boston Scientific Corporation.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook